RXO SCHEDULE 13G/A: SEC filing

An institutional holder

Filed with the SEC on Nov 6, 2026 · accession 0000940594-26-000061

RXO filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 6, 2026. An institutional holder filed an amended Schedule 13G for RXO, Inc., indicating a change in passive ownership position. The stock moved -1.0% by the first close after the filing.

Summary of the filing

An institutional holder filed an amended Schedule 13G for RXO, Inc., indicating a change in passive ownership position. The filing does not disclose a specific corporate event.

For details, click here →

Key details

IssuerRXO, Inc.

How RXO stock reacted

Close before

$27.88

Nov 5, 2026

First close after

-1.00%

$27.60

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for RXO, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for RXO?

Click here

Frequently asked questions

What did RXO file with the SEC on Nov 6, 2026?

RXO filed a SCHEDULE 13G/A (SEC filing). An institutional holder filed an amended Schedule 13G for RXO, Inc., indicating a change in passive ownership position. The filing does not disclose a specific corporate event.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did RXO stock react to this filing?

RXO closed at $27.88 before the filing and $27.60 on Nov 6, 2026 (-1.00%).

Other RXO SEC filings

Get alerts when RXO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

RXO overview RXO analysis RXO news Latest SEC filings